-
Je něco špatně v tomto záznamu ?
Does the healthy vaccinee bias rule them all? Association of COVID-19 vaccination status and all-cause mortality from an analysis of data from 2.2 million individual health records
T. Fürst, A. Bazalová, T. Fryčák, J. Janošek
Jazyk angličtina Země Kanada
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 1996
Free Medical Journals
od 1996 do Před 1 rokem
Open Access Digital Library
od 1996-01-01
Open Access Digital Library
od 1996-07-01
ROAD: Directory of Open Access Scholarly Resources
- MeSH
- aklarubicin MeSH
- COVID-19 * prevence a kontrola MeSH
- lidé MeSH
- retrospektivní studie MeSH
- vakcinace MeSH
- vakcíny proti COVID-19 MeSH
- zdraví MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
OBJECTIVES: We investigated the validity of claims of the healthy vaccinee effect (HVE) in COVID-vaccine studies by analyzing associations between all-cause mortality (ACM) and COVID-19 vaccination status. METHODS: Approximately 2.2 million individual records from two Czech health insurance companies were retrospectively analyzed. Each age group was stratified according to the vaccination status (unvaccinated vs. individuals less than 4 weeks vs. more than 4 weeks from Doses 1, 2, 3, and 4 or more doses of vaccine). ACMs in these groups were computed and compared. RESULTS: Consistently over datasets and age categories, ACM was substantially lower in the vaccinated than unvaccinated groups regardless of the presence or absence of a wave of COVID-19 deaths. Moreover, the ACMs in groups more than 4 weeks from Doses 1, 2, or 3 were consistently several times higher than in those less than 4 weeks from the respective dose. HVE appears to be the only plausible explanation for this, which is further corroborated by a created mathematical model. CONCLUSIONS: In view of the presence of HVE, the baseline difference in the frailty of vaccinated and unvaccinated populations in periods without COVID-19 must be taken into account when estimating COVID-19 vaccine effectiveness from observational data.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24014161
- 003
- CZ-PrNML
- 005
- 20240905133819.0
- 007
- ta
- 008
- 240725e20240222xxc f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ijid.2024.02.019 $2 doi
- 035 __
- $a (PubMed)38401782
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxc
- 100 1_
- $a Fürst, Tomáš $u Department of Mathematical Analysis and Applications of Mathematics, Faculty of Science, Palacky University Olomouc, Olomouc, Czech Republic
- 245 10
- $a Does the healthy vaccinee bias rule them all? Association of COVID-19 vaccination status and all-cause mortality from an analysis of data from 2.2 million individual health records / $c T. Fürst, A. Bazalová, T. Fryčák, J. Janošek
- 520 9_
- $a OBJECTIVES: We investigated the validity of claims of the healthy vaccinee effect (HVE) in COVID-vaccine studies by analyzing associations between all-cause mortality (ACM) and COVID-19 vaccination status. METHODS: Approximately 2.2 million individual records from two Czech health insurance companies were retrospectively analyzed. Each age group was stratified according to the vaccination status (unvaccinated vs. individuals less than 4 weeks vs. more than 4 weeks from Doses 1, 2, 3, and 4 or more doses of vaccine). ACMs in these groups were computed and compared. RESULTS: Consistently over datasets and age categories, ACM was substantially lower in the vaccinated than unvaccinated groups regardless of the presence or absence of a wave of COVID-19 deaths. Moreover, the ACMs in groups more than 4 weeks from Doses 1, 2, or 3 were consistently several times higher than in those less than 4 weeks from the respective dose. HVE appears to be the only plausible explanation for this, which is further corroborated by a created mathematical model. CONCLUSIONS: In view of the presence of HVE, the baseline difference in the frailty of vaccinated and unvaccinated populations in periods without COVID-19 must be taken into account when estimating COVID-19 vaccine effectiveness from observational data.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a COVID-19 $x prevence a kontrola $7 D000086382
- 650 _2
- $a vakcíny proti COVID-19 $7 D000086663
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a aklarubicin $7 D015250
- 650 _2
- $a zdraví $7 D006262
- 650 _2
- $a vakcinace $7 D014611
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Bazalová, Angelika $u Department of Mathematical Analysis and Applications of Mathematics, Faculty of Science, Palacky University Olomouc, Olomouc, Czech Republic
- 700 1_
- $a Fryčák, Tadeáš $u Department of Mathematical Analysis and Applications of Mathematics, Faculty of Science, Palacky University Olomouc, Olomouc, Czech Republic
- 700 1_
- $a Janošek, Jaroslav $u Department of Mathematical Analysis and Applications of Mathematics, Faculty of Science, Palacky University Olomouc, Olomouc, Czech Republic; Center for Health Research, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic. Electronic address: janosek@correcta.cz
- 773 0_
- $w MED00005677 $t International journal of infectious diseases $x 1878-3511 $g Roč. 142 (20240222), s. 106976
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38401782 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240725 $b ABA008
- 991 __
- $a 20240905133813 $b ABA008
- 999 __
- $a ok $b bmc $g 2143757 $s 1226027
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 142 $c - $d 106976 $e 20240222 $i 1878-3511 $m International journal of infectious diseases $n Int J Infect Dis $x MED00005677
- LZP __
- $a Pubmed-20240725